Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M200205-JLR200 on August 16, 2002

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200205-JLR200v1
43/11/1920    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorngate, F. E.
Right arrow Articles by Williams, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorngate, F. E.
Right arrow Articles by Williams, D. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 43, 1920-1926, November 2002
Copyright © 2002 by Lipid Research, Inc.

Altered adrenal gland cholesterol metabolism in the apoE-deficient mouse

Fayanne E. Thorngate*, Penelope A. Strockbine*, Sandra K. Erickson{dagger} and David L. Williams1,*

* Department of Pharmacological Sciences, University Medical Center, State University of New York at Stony Brook, Stony Brook, NY 11794
{dagger} Department of Medicine, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, CA 94143

Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200205-JLR200

1 To whom correspondence should be addressed. e-mail: dave{at}pharm.sunysb.edu


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Previous studies suggest the hypothesis that apoE produced by adrenocortical cells modulates cellular cholesterol metabolism to enhance the storage of esterified cholesterol (EC) at the expense of cholesterol delivery to the steroidogenic pathway. In the present study, parameters of adrenal cholesterol metabolism and corticosteroid production were examined in wild type and apoE-deficient (apoe-/-) mice. Adrenal gland EC content and the EC/free cholesterol (FC) ratio in mice stressed by adrenocorticotropin (ACTH) treatment or saline injection were reduced in apoe-/- compared to apoe+/+ mice. Relative to apoe+/+ mice, apoE deficiency also resulted in increased levels of plasma corticosterone in the basal state, in response to acute or long-term ACTH treatment, and after a swim-induced neuroendocrine-directed stress test. Measurements of adrenal gland scavenger receptor class B, type I (SR-BI), LDL receptor, and LDL receptor related protein (LRP) levels and the activities of ACAT or HMG-CoA reductase showed no difference between genotypes. Apoe-/- and apoe+/+ mice showed similar quantitative increases in LDL receptors, SR-BI, adrenal weight gain, and ACAT activities in response to ACTH, and both genotypes had similar basal plasma ACTH concentrations.

These results suggest that the effects of apoE deficiency reflect events at the level of the adrenal gland and are specific to changes in cholesterol accumulation and corticosterone production. Further, these findings support the hypothesis that apoE acts to enhance adrenocortical EC accumulation and diminish corticosterone production.

Abbreviations: ACTH, adrenocorticotropin; EC, esterified cholesterol; FC, free cholesterol; LRP, LDL receptor related protein; SR-BI, scavenger receptor class B, type I

Supplementary key words lipoprotein • steroidogenesis • corticosterone • scavenger receptor class B type I • SR-BI • LDL receptor


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Apolipoprotein E (apoE) is a prominent component of plasma lipoproteins and serves to mediate endocytic uptake of remnant lipoproteins by members of the LDL receptor family (1). In contrast to other apolipoproteins, apoE is expressed in many peripheral tissues including brain, adipose, skin, kidney, lung, and steroidogenic organs such as adrenal gland, ovary, and testis (2–8). Studies with humans, nonhuman primates, and rats show that the level of apoE gene expression in the adrenal gland is similar to that in liver and may account for as much as 0.5–1% of total tissue protein synthesis (2, 8–11). ApoE mRNA and protein are expressed in adrenocortical zona fasciculata and zona reticularis cells, the sites of glucocorticoid production and cholesteryl ester storage in the adrenal cortex (12, 13). Electron microscopic immunolocalization studies show apoE intracellularly within vesicular structures of the secretory and endocytic pathways and prominently on the plasma membrane both in cell surface microvillar channels and in non-microvillar regions of the membrane (13).

The high expression of apoE in adrenocortical cells and its pattern of regulation suggest that locally-derived apoE may facilitate the acquisition of lipoprotein cholesterol, alter cellular esterified cholesterol (EC) storage, or modulate the availability of cholesterol for steroidogenesis. For example, in rat adrenal gland, apoE expression is regulated in direct proportion to EC stores and inversely to the level of steroid production (11, 12). In studies with cultured murine Y1 adrenocortical cells, constitutive expression of human apoE leads to enhanced EC accumulation and a suppression of steroid production (14, 15). In addition, inducible expression of apoE in Y1 cells enhances both the endocytic and selective uptake of LDL EC (16).

The studies noted above support the hypothesis that local apoE production modulates cellular cholesterol metabolism to enhance the storage of lipoprotein-derived EC at the expense of cholesterol delivery to the steroidogenic pathway. In the present study, parameters of adrenal cholesterol metabolism and corticosteroid production have been examined in wild type and apoE-deficient mice. The data suggest that apoE deficiency leads to an altered disposition of adrenal cholesterol with more directed toward steroid production and less toward EC storage. These data obtained with an in vivo mouse model support the hypothesis that local apoE synthesis modulates cellular cholesterol metabolism.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Animals
ApoE-deficient (apoE-/-) mice on a mixed C57BL/6J x 129 background were kindly provided by N. Maeda (Department of Pathology, University of North Carolina, Chapel Hill, NC) (17). The mice were bred as heterozgotes to C57BL/6J mice for four generations, and then bred to homozygosity. Control (apoE+/+) mice were obtained in the same fashion. In several experiments, control C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, ME), in which case the mice were acclimated in the animal colony for at least 1 week prior to experiments. Animals were maintained on a chow diet with a 12 h dark/12 h light cycle, and all experiments were initiated at 2 h into the light cycle. The experiments reported here were carried out over a period of 3.5 years using males that ranged from 2–5 months of age. Adrenal function is subject to variation due to stress in the colony (animal care procedures) that is difficult to control perfectly over a long period of time. Thus, it is not always possible to make quantitative comparisons between experiments performed at different times. However, considerable effort was made to control for potential variables within any experiment by using 1) age matched animals, 2) by initiating experiments at 2 h into the light cycle, and 3) by alternating the handling (bleeding, sacrifice, injections) of apoe-/- and apoe+/+ mice within an experiment. All reported comparisons are between apoe-/- and apoe+/+ mice in the same experiment. True control values (i.e., unstressed) were obtained by killing animals within a minute upon removal from the cage. Controls in experiments involving injections or non-terminal bleeding were, by necessity, subject to the stress of the experimental protocol.

Experimental treatments
For swim stress tests, mice were bled from the retroorbital plexus into EDTA coated tubes, swum for 3 min at 5°C, rested for 17 min at room temperature, anesthetized with an intramuscular injection of 50 µl ketamine-xylazine (3:2, v/v), and bled from the heart (18). For acute adrenocorticotropin (ACTH) responsiveness, mice received an intraperitoneal injection of either 0.1 ml saline or 0.1 ml saline containing 200 mU ACTH (Acthar, Rorer Pharmaceuticals, Fort Washington, PA). Mice were anaesthetized as above and killed after 40 min. For long term ACTH treatment, mice received injections of 4 U ACTH or saline as above at 0 and 12 h. At 24 h, mice were injected with saline or 200 mU ACTH and were killed after 40 min. Plasma was prepared for corticosterone assay and adrenal glands were removed, trimmed of adipose tissue, and frozen for subsequent cholesterol measurement.

Adrenal gland cholesterol
Adrenal glands from individual mice were homogenized in 0.2 ml PBS in a ground glass tissue grinder that was rinsed with another 0.2 ml PBS. The pooled homogenate and rinse were extracted with 1.5 ml CHCl3-MeOH (1:2, v/v) for 15 min at room temperature, centrifuged for 15 min at 1,000 g, and the supernatant was removed to a new tube. The pellet was dissolved in 0.4 N NaOH and assayed for protein by the method of Lowry (19). To the supernatant were added 0.5 ml H2O and 0.5 ml CHCl3, the sample was mixed, centrifuged to separate phases, and the CHCl3 phase was removed and dried down under N2. Free cholesterol and total cholesterol were measured with enzymatic colorimetric assays (Wako Chemical) adapted to a 96 well plate format. Cholesteryl ester was determined by difference.

Plasma corticosterone and ACTH
Blood was collected into EDTA rinsed syringes or capillary tubes, centrifuged twice to remove cells, and stored at -80°C until assay. For corticosterone measurement, plasma was mixed with 10 vol of ethanol for 10 min at room temperature, centrifuged at 10,000 g for 10 min to remove protein, and aliquots were dried and assayed for corticosterone by radioimmunoassay (Endocrine Sciences, antiserum B3-163). The distributon of corticosterone between the lipoprotein and non-lipoprotein fractions of plasma was determined after ultracentrifugation of pooled plasma samples adjusted to {rho} = 1.21 gm/ml with KBr (20). The {rho} > 1.21 gm/ml and the {rho} < 1.21 gm/ml fractions were adjusted to equal KBr concentrations, aliquots were diluted with 10 vol of ethanol, centrifuged to remove KBr, dried, and assayed for corticosterone. Plasma ACTH was determined by ELISA using a commercial kit according to the manufacturer's protocol (Sangui Biotech, Santa Ana, CA).

Enzyme assays and Western blots
Adrenal glands from 10–20 mice were pooled and homogenized in ice cold 0.6 ml 0.1 M sucrose, 0.05 M KCl, 0.04 M KH2PO4, 0.03 M EDTA, 10 µg/ml aprotinin, pH 7.4. Aliquots of the homogenate were frozen in liquid N2, and stored at -80°C for Western blot analysis. The remainder of the homogenate was centrifuged at 4°C at 12,000 g for 15 min, and the supernatant was centrifuged at 105,000 g for 45 min. The microsome pellet was rehomogenized in 0.6 ml of the above buffer, centrifuged at 105,000 g for 45 min, and the washed microsomal pellet was resuspended in 0.3 ml buffer, frozen in liquid N2, and stored at -80°C. Liver homogenate and microsomes were prepared in the same manner except with 1 gm of liver homogenized in 5 ml. Microsomes were assayed for HMG-CoA reductase activity and ACAT as previously described (21). ACAT was measured using both endogenous and exogenous substrate.

For Western blot analysis tissue homogenates (50 µg protein) were analyzed by SDS 8% polyacrylamide gel electrophoresis followed by transfer of the proteins to a nitrocellulose membrane. Blots were probed with antibodies against the LDL receptor and the LDL receptor related protein (LRP) (21, 22) and with antibody to scavenger receptor class B, type I (SR-BI) (23). After incubation with horseradish peroxidase-conjugated secondary antibody, immunoreactive bands were visualized by enhanced chemiluminescence (Pierce) and quantified by densitometry.

Adrenal morphology and ultrastructure
For light microscopy, mice were perfused through the left ventrical with PBS followed by 4% formaldehyde in PBS. Frozen sections were stained with oil red O and lightly counterstained with hematoxylin as described (18). For electron microscopy, mice were perfused at constant pressure (110 mm Hg) through the left ventrical first with 0.5 ml 0.1 M sodium cacodylate, pH 7.4, followed by 25 ml freshly prepared 2% glutaraldehyde, 1% paraformaldehyde in 0.1 M sodium cacodylate, pH 7.4. Tissue preparation, staining, electron microscopy, and measurement of microvillar channels were carried out with sections from two mice of each genotype (18). Tissue morphology was also evaluated by light microscopy using toluidine blue-stained epon sections (0.5 µm) of adrenal gland and liver tissue.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Plasma and adrenal cholesterol metabolism
Previous studies indicated that adrenal apoE expression is positively correlated with adrenal EC accumulation, suggesting a potential role for apoE in the maintenance or acquisition of adrenal EC stores (11).

Accordingly, plasma and adrenal gland cholesterol concentrations were determined in apoe+/+ and apoe-/- mice under basal, unstressed, conditions and in response to either saline or ACTH treatments. The data in Table 1 show the expected accumulation of plasma cholesterol in the apoe-/- mice in the basal state and in all experimental groups. Acute ACTH treatment for 40 min had no effect on plasma cholesterol in the apoe+/+ or apoe-/- mice. Long term ACTH treatment over a 24 h period, however, elevated both plasma free cholesterol (FC) and EC in apoe+/+ mice and reduced the ratio of EC/FC compared to apoe+/+ mice in the basal state or after acute ACTH or saline treatment. A similar trend toward elevated plasma FC (15–20% increased) was seen with long term ACTH treatment of apoe-/- mice, but this did not reach statistical significance. Apoe-/- mice subjected to long term saline or ACTH treatments also showed a significant reduction in the ratio of EC/FC compared to apoe-/- mice in the basal state or after acute ACTH or saline treatments.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Effect of ACTH treatment on plasma cholesterol concentration

 
In addition to increasing corticosteroid production, long term ACTH treatment stimulates an increase in adrenal gland wet weight. As shown in Table 2, long term ACTH treatment increased adrenal weight similarly in both apoe+/+ and apoe-/- mice. No differences in adrenal weight between apoe+/+ and apoe-/- mice were seen in any experimental group.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Adrenal weight response to ACTH

 
In basal unstressed mice, we observed no significant differences in total adrenal cholesterol or in EC between apoe-/- and apoe+/+ mice, but apoe-/- mice had reduced adrenal FC (74 ± 2 vs. 63 ± 3 µg/mg protein, P < 0.01). The data in Fig. 1 and Table 3 compare the adrenal cholesterol responses of apoe+/+ and apoe-/- mice to acute and long term ACTH treatments. With acute ACTH treatment, apoe+/+ mice showed an increase in adrenal total cholesterol that was due to EC accumulation (Fig. 1A, B). In comparison to apoe+/+ mice, the apoe-/- mice showed two differences. First, the adrenal contents of total cholesterol and EC were less in the apoe-/- mice with both acute saline and acute ACTH treatments (Fig. 1A, B). In addition, the FC content was lower in the acute saline treated apoe-/- mice (Table 3). Second, whereas the apoe+/+ mice showed an increase in adrenal total cholesterol and EC in response to acute ACTH, the apoe-/- mice did not.



View larger version (21K):
[in this window]
[in a new window]
  		Fig. 1. Adrenal gland cholesterol content in response to adrenocorticotropin (ACTH). Mice (n = 20) were injected with saline or ACTH for either an acute (A and B) or long term (C and D) treatment as described in Experimental Procedures. Open bars, total cholesterol; solid bars, esterified cholesterol. a P < 0.02 versus respective apoe+/+ group. b P < 0.05 versus respective saline-treated group.

 

View this table:
[in this window]
[in a new window]
  		TABLE 3. Adrenal gland free cholesterol content in response to ACTH

 
With long term saline or ACTH treatment, the apoe-/- mice had significantly reduced levels of adrenal total cholesterol and EC in comparison to apoe+/+ mice (Fig. 1C, D). In addition, adrenal FC content was lower in the apoe-/- mice after long term ACTH treatment (Table 3). In contrast to the effects of acute ACTH treatment, apoe+/+ mice treated with ACTH for 24 h showed no increase in total cholesterol or EC, but did show an increase in adrenal FC content (Table 3). Apoe-/- mice showed a significant reduction in EC in response to long term ACTH treatment (Fig. 1C, D), as well as the increase in adrenal FC content (Table 3). As compared to the apoe+/+ mice, the EC/FC ratio (Table 3) was considerably lower in the apoe-/- mice in all treatment groups and was reduced with long term ACTH treatment in both apoe+/+ and apoe-/- mice. This result suggests a greater mobilization of adrenal EC stores with long term, as compared to acute, ACTH treatment. The mobilization of EC was greater in the apoe-/- mice.

Adrenal receptor levels and enzyme activities
A variety of receptor levels were determined by Western blotting of homogenates of adrenal glands from apoe-/- and apoe+/+ mice. As shown in Table 4, little or no difference was seen in the levels of SR-BI, LDL receptor, or the LRP between apoe-/- and apoe+/+ mice in the basal state. Both genotypes showed a 3.5-fold increase in SR-BI and 1.5-fold increase in LDL receptor levels in response to ACTH treatment for 24 h. Measurements made with liver homogenates also showed no difference in receptor levels between apoe-/- and apoe+/+ mice.


View this table:
[in this window]
[in a new window]
  		TABLE 4. Receptor and enzyme activities in apoe+/+ and apoe-/- mice

 
Measurements of adrenal microsomal HMG-CoA reductase activity showed little or no difference between apoe-/- and apoe+/+ mice before or after ACTH treatment (Table 4). Similarly, no differences were noted between genotypes in reductase activity in liver microsomes. Adrenal ACAT activity with either endogenous or exogenous substrate was similar between apoe-/- and apoe+/+ mice and showed an approximately 2-fold increase in both genotypes in response to ACTH. No difference was noted between genotypes in ACAT activity in liver microsomes.

Plasma corticosterone accumulation
Plasma corticosterone levels were elevated in apoe-/- mice in comparison to apoe+/+ mice in the basal state (Fig. 2A , white bar) as well as in response to both acute (Fig. 2A, solid bars) and 24 h ACTH treatments (Fig. 2B, solid bars). A trivial explanation for this difference is that a greater fraction of the plasma steroid partitions into the much larger pool of plasma lipoproteins in the apoe-/- mice but that the levels of free corticosterone and that bound to binding globulins is the same. To test this point, plasma was pooled from stressed mice of each genotype, and separated into {rho} > 1.21 gm/ml and {rho} < 1.21 gm/ml fractions to measure lipoprotein-associated and lipoprotein-unassociated corticosterone. The results showed that 75% of the corticosterone was in the {rho} > 1.21 gm/ml fraction and 25% in the {rho} < 1.21 gm/ml fraction in both genotypes (data not shown). Additionally, no significant correlation was observed between total plasma cholesterol and plasma corticosterone in either apoe-/- or apoe+/+ mice. Thus, the elevated plasma corticosterone in apoe-/- mice appears to reflect a physiological difference that is not explained by the much larger plasma lipid pool in these mice.



View larger version (14K):
[in this window]
[in a new window]
  		Fig. 2. Plasma corticosterone in response to ACTH. Mice were untreated (A, basal, left bar; apoe+/+ n = 18; apoe-/- n = 31), or injected with saline (middle bar) or ACTH (solid bars) for either an acute (A, n = 20) or long term (B, n = 10) treatment as described in Experimental Procedures. a P < 0.01 versus respective apoe+/+ group. b P < 0.07 versus respective apoe+/+ group.

 
To determine whether elevated basal plasma corticosterone in apoe-/- mice is an effect at the adrenal gland or reflects increased ACTH stimulation through the hypothamic-hypophyseal axis, plasma ACTH concentrations were measured. No significant difference between genotypes was found (apoe+/+, 46 ± 14 pg/ml, n = 14; apoe-/-, 68 ± 13 pg/ml, n = 24). Additionally, plasma corticosterone accumulation in response to an acute swim stress test was determined as a measure of a central nervous system-directed adrenal response. As shown in Fig. 3 , as compared to the apoe+/+ mice, corticosterone values were elevated in the apoe-/- mice before and after the swim stress test. The fold increase in corticosterone upon stress was approximately the same in both genotypes (apoe+/+ 3.3 vs. apoe-/- 2.6).



View larger version (14K):
[in this window]
[in a new window]
  		Fig. 3. Plasma corticosterone in response to a swim stress test. Plasma corticosterone was measured (n = 18) before (open bars) and after (solid bars) a swim stress test as described in Experimental Procedures. a P < 0.01 versus respective apoe+/+ group.

 
Adrenal morphology and HDL localization in microvillar channels
Adrenal morphology was evaluated at the light microscopic level by by oil red O/hematoxylin staining of cryosections and by toluidine blue staining of thick sections of epon-embedded tissue prepared for electron microscopy. No significant differences were noted between apoe-/- and apoe+/+ tissue (data not shown). Unlike the situation in the skin of apoe-/- mice where macrophage foam cells and inflammatory cells accumulate (24), the adrenal gland showed no signs of inflammation or macrophage foam cells (data not shown). Oil red O staining appeared somewhat less dense in some adrenal glands of apoe-/- mice, but this difference was not consistently observed. Liver sections from apoe-/- mice, but not apoe+/+ mice, showed many lipid laden Kupffer cells, granuloma-like accumulations of histiocytes in subendothelial locations, and hepatocytes containing increased numbers of lipid droplets; the latter point was noted previously (25). Adrenal ultrastructure at the electron microscopic level also appeared to be normal in apoe-/- mice. The width of adrenal microvillar channels (apoe+/+, 12.7 ± 2.3 nm, n = 51; apoe-/-, 13.5 ± 2.8 nm, n = 68) and appearance of HDL particles in the channels were the same in both genotypes.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
This study shows significant differences in adrenal gland cholesterol metabolism in apoe-/- mice. The most prominent effects were observed in adrenal cholesterol content in ACTH-treated mice or mice stressed by saline injection. In both groups, adrenal EC content and the EC/FC ratio were lower in apoe-/- mice, suggesting a reduced capacity to maintain adrenal cholesterol stores during stress. In some groups adrenal FC content was also reduced in apoe-/- adrenal glands. These results complement data from a previous study that showed increased FC and EC accumulation in murine Y1 adrenal cells that over-expressed apoE (14). Additionally, the present results complement previous studies in the rat that demonstrated a direct correlation between the levels of apoE mRNA and adrenal EC content under conditions that produced a 15-fold range of these parameters (11). Taken together with these previous studies, the present findings in the apoe-/- mouse support a physiological role for apoE in maintaining the EC content of adrenocortical cells. Because these changes were seen only in adrenal glands from stressed mice, apoE may act to maintain adrenal cholesterol stores in the face of increased cholesterol utilization for steroid production.

The absence of apoE also resulted in increased levels of plasma corticosterone in the apoe-/- mouse in the basal state, in response to acute or long-term ACTH treatment, and after a swim-induced neuroendocrine-directed stress. Increased plasma corticosterone in the basal state or in response to long-term ACTH treatment could result from increased adrenal production or reduced plasma clearance. The rapid increase in plasma corticosterone following a 3-min swim or an acute ACTH treatment, however, suggests that elevated corticosterone levels in the apoe-/- mouse result from greater adrenal hormone production. The present results do not distinguish between an indirect systemic effect and a direct adrenal effect of the absence of apoE on steroid production. However, a direct effect of apoE on adrenocortical cell steroid production is suggested by previous studies that showed suppression of steroid production in murine Y1 adrenal cells that constitutively over-express apoE (15). Additionally, the finding that apoE mRNA concentrations and relative apoE synthesis rates are very high in adrenocortical cells of humans, non-human primates, and rodents supports a local effect of apoE (2, 4, 5, 8, 10). This interpretation of the present findings also is supported by the inverse relationship between adrenal apoE mRNA content and serum corticosteroids observed in the rat (11). The mechanism through which steroid production is increased in the apoe-/- adrenal gland may reflect the failure of apoE to dampen responsiveness through the protein kinase A pathway and suppress expression of the mRNA for the cholesterol side chain cleavage enzyme. ApoE exhibits these effects when over expressed in cultured murine adrenal cells (26, 27).

The present results showing elevated corticosterone levels in apoe-/- mice are in agreement with a recent study (28), although a few differences were noted. Raber et al. (28) saw elevated corticosterone levels in 6-month-old apoe-/- mice but not in 3-month-old mice, whereas in the present study elevated corticosterone levels were seen in 2–5-month-old apoe-/- mice. We observed no correlation between plasma corticosterone levels and animal age in control or ACTH treated mice. Raber et al. (28) also reported increased lipid droplets in the adrenal cortex and medulla of apoe-/- mice as judged by Nile red staining suggesting increased EC accumulation. In the present study we observed decreased EC accumulation in the adrenal glands of apoe-/- mice by cholesterol measurement, occasional but inconsistent decreases in oil red O staining in the adrenal cortex, and no oil red O staining in the adrenal medulla. These discrepancies with Raber et al. (28) may reflect methodological differences.

Among the parameters studied, the effects of apoE deficiency are specific to adrenal cholesterol accumulation and corticosterone production. No significant differences were observed in adrenal LDL or HDL receptor levels, ACAT or HMG-CoA reductase activities, or in the response of these parameters to ACTH treatment. Similarly, adrenal weight gain in response to ACTH treatment was similar in both genotypes. Additionally, the absence of morphological differences at the light and electron microscopic levels and the absence of inflammatory cells in the adrenal glands of apoe-/- mice suggest that the effects of apoE deficiency are relatively specific to changes in cholesterol accumulation and corticosterone production. The finding of similar basal plasma ACTH levels in the apoe-/- and apoe+/+ mice suggests that the observed differences in adrenal cholesterol metabolism and steroid production are due to apoE effects on adrenocortical cells and not to effects on a neuroendocrine pathway. This point is also supported by the similar quantitative responses of both genotypes in the ACTH stimulation of LDL receptors, SR-BI, adrenal weight gain, and ACAT activities whereas at the same time apoe-/- mice showed elevated plasma corticosterone levels and a decreased capacity to maintain adrenal cholesterol stores when stressed.

The mechanism by which apoE expression alters adrenal cholesterol metabolism is unclear but could involve changes in lipoprotein cholesterol uptake or in cholesterol trafficking or utilization in adrenocortical cells. Previous studies in Y1 adrenocortical cells showed that apoE expression increases the selective uptake of LDL EC via a pathway that does not involve SR-BI (16, 29). A smaller increase in the endocytic uptake of LDL EC was also seen upon apoE expression. Similar effects of apoE could contribute to the maintenance of adrenal gland EC during stress, although HDL, and not LDL, appears to provide most of the adrenal gland EC in vivo (18, 30). Further studies on the effect of apoE on HDL and LDL EC uptake into adrenocortical cells may be informative on this issue.


   ACKNOWLEDGMENTS
 
This research was supported by Grants HL32868 and HL52069 from the National Institutes of Health and a Merit Award from the Department of Veterans Affairs. Steven Lear and Jacqueline Parton provided excellent technical assistance.

Manuscript received May 23, 2002 and in revised form August 5, 2002.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Mahley, R. W., and Z-S. Ji. 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40: 1–16.[Abstract/Free Full Text]

  2. Blue, M-L., D. L. Williams, S. Zucker, S. A. Khan, and C. B. Blum. 1983. Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. Proc. Natl. Acad. Sci. USA. 80: 283–287.[Abstract/Free Full Text]

  3. Dawson, P. A., N. Schechter, and D. L. Williams. 1986. Induction of rat E and chicken A-1 apolipoproteins and mRNAs during optic nerve degeneration. J. Biol. Chem. 261: 5681–5684.[Abstract/Free Full Text]

  4. Driscoll, D. M., and G. S. Getz. 1984. Extrahepatic synthesis of apolipoprotein E. J. Lipid Res. 25: 1368–1379.[Abstract]

  5. Elshourbagy, N. A., W. S. Liao, R. W. Mahley, and J. M. Taylor. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenal, as well as in the liver and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA. 82: 203–207.[Abstract/Free Full Text]

  6. Fenjves, E. S., D. A. Gordon, L. K. Pershing, D. L. Williams, and L. B. Taichman. 1989. Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: Implications for epidermal function and gene therapy. Proc. Natl. Acad. Sci. USA. 86: 8803–8807.[Abstract/Free Full Text]

  7. Lenich, C., B. Brecher, S. Makrides, A. Chobanian, and V. I. Zannis. 1988. Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues. J. Lipid Res. 29: 755–764.[Abstract]

  8. Williams, D. L., P. A. Dawson, T. C. Newman, and L. L. Rudel. 1985. Apolipoprotein E synthesis in peripheral tissues of nonhuman primates. J. Biol. Chem. 260: 2444–2451.[Abstract/Free Full Text]

  9. Dawson, P. A., L. M. Lukaszewski, P. E. Ells, C. C. Malbon, and D. L. Williams. 1989. Quantification and regulation of apolipoprotein E expression in rat Kupffer cells. J. Lipid Res. 30: 403–413.[Abstract]

  10. Newman, T. C., P. A. Dawson, L. L. Rudel, and D. L. Williams. 1985. Quantitation of apolipoprotein E messenger RNA in the liver and peripheral tissues of nonhuman primates. J. Biol. Chem. 260: 2452–2457.[Abstract/Free Full Text]

  11. Prack, M. M., M. Nicosia, D. L. Williams, and J. Gwynne. 1991. Relationship between apolipoprotein E mRNA expression and tissue cholesterol content in rat adrenal gland. J. Lipid Res. 32: 1611–1618.[Abstract]

  12. Nicosia, M., M. M. Prack, and D. L. Williams. 1992. Differential regulation of apolipoprotein E mRNA in z. fasciculata cells of rat adrenal gland determined by in situ hybridization. Mol. Endocrinol. 6: 288–298.[Abstract/Free Full Text]

  13. Williams, D. L., J. S. Wong, S. L. Wissig, and R. L. Hamilton. 1995. Cell surface "blanket" of apolipoprotein E on rat adrenocortical cells. J. Lipid Res. 36: 745–758.[Abstract]

  14. Prack, M. M., G. H. Rothblat, S. K. Erickson, M. E. Reyland, and D. L. Williams. 1994. Apolipoprotein E expression in Y1 arenal cells is associated with increased intracellular cholesterol content and reduced free cholesterol efflux. Biochemistry. 33: 5049–5055.[CrossRef][Medline]

  15. Reyland, M. E., J. T. Gwynne, P. Forgez, M. M. Prack, and D. L. Williams. 1991. Expression of the human apoE gene suppresses steroidogenesis in mouse Y1 adrenal cells. Proc. Natl. Acad. Sci. USA. 88: 2375–2379.[Abstract/Free Full Text]

  16. Swarnakar, S., M. E. Reyland, J. Deng, S. Azhar, and D. L. Williams. 1998. Selective uptake of low density lipoprotein-cholesteryl ester is enhanced by inducible apolipoprotein E expression in cultured mouse adrenocortical cells. J. Biol. Chem. 273: 12140–12147.[Abstract/Free Full Text]

  17. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89: 4471–4475.[Abstract/Free Full Text]

  18. Plump, A. S., S. K. Erickson, W. Weng, J. S. Partin, J. L. Breslow, and D. L. Williams. 1996. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J. Clin. Invest. 97: 2660–2671.[Medline]

  19. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265–275.[Free Full Text]

  20. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composistion of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345–1353.

  21. Erickson, S. K., S. R. Lear, M. A. Barker, and T. A. Musliner. 1990. Regulation of cholesterol metabolism in the ethionine induced premalignant rat liver. J. Lipid Res. 31: 933–945.[Abstract]

  22. Voyno-Yasenetskaya, T. A., L. G. Dobbs, S. K. Erickson, and R. L. Hamilton. 1993. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc. Natl. Acad. Sci. USA. 90: 4256–4260.[Abstract/Free Full Text]

  23. Temel, R. E., B. Trigatti, R. B. DeMattos, S. Azhar, M. Krieger, and D. L. Williams. 1997. Scavenger receptor B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc. Natl. Acad. Sci. USA. 94: 13600–13605.[Abstract/Free Full Text]

  24. Feingold, K.R., P.M. Elias, M. Mao-Qiang, M. Fartasch, S. H. Zhang, and N. Maeda. 1995. Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. Journal of Investigative Dermatology. 104: 246–250.[CrossRef][Medline]

  25. Kuipers, F., J. M. van Ree, M. H. Hofker, H. Wolters, V. In't, R. Havinga, R. J. Vonk, H. M. Princen, and L. M. Havekes. 1996. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology. 24: 241–247.[CrossRef][Medline]

  26. Reyland, M. E., M. M. Prack, and D. L. Williams. 1992. Increased expression of protein kinase C in Y1 cells which express apolipoprotein E decreases basal steroidogenesis by inhibiting expression of P450-cholesterol side chain cleavage enzyme mRNA. J. Biol. Chem. 267: 17935–17942.

  27. Reyland, M. E., and D. L. Williams. 1991. Suppression of cAMP-mediated signal transduction in mouse adrenocortical cells which express apolipoprotein E. J. Biol. Chem. 266: 21099–21194.[Abstract/Free Full Text]

  28. Raber, J., S. F. Akana, S. Bhatnagar, M. F. Dallman, D. Wong, and L. Mucke. 2000. Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. J. Neurosci. 20: 2064–2071.[Abstract/Free Full Text]

  29. Swarnakar, S., J. Beers, D. K. Strickland, S. Azhar, and D. L. Williams. 2001. The apolipoprotein E-dependent low density lipoprotein cholesteryl ester selective uptake pathway in murine adrenocortical cells involves chondroitin sulfate proteoglycans and an {alpha}-2-macroglobulin receptor. J. Biol. Chem. 276: 21121–21128.[Abstract/Free Full Text]

  30. Glass, C., R. C. Pittman, M. Civen, and D. Steinberg. 1985. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in Vivo and by adrenal cells and hepatocytes in Vitro. J. Biol. Chem. 260: 744–750.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
D. J. Espiritu and T. Mazzone
Oxidative Stress Regulates Adipocyte Apolipoprotein E and Suppresses Its Expression in Obesity
Diabetes, November 1, 2008; 57(11): 2992 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. L. Dichek, N. Agrawal, N. E. Andaloussi, and K. Qian
Attenuated corticosterone response to chronic ACTH stimulation in hepatic lipase-deficient mice: evidence for a role for hepatic lipase in adrenal physiology
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E908 - E915.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200205-JLR200v1
43/11/1920    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorngate, F. E.
Right arrow Articles by Williams, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorngate, F. E.
Right arrow Articles by Williams, D. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Advertisement
spacer
Advertisement
Advertisement